• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alnylam Pharmaceuticals Inc

+ Add to Watchlist

ALNY:US

92.7400 USD 1.9800 2.09%

As of 16:30:00 ET on 10/31/2014.

Snapshot for Alnylam Pharmaceuticals Inc (ALNY)

Open: 95.8000 Day's Range: 91.7600 - 99.2400 Volume: 913,687
Previous Close: 94.7200 52wk Range: 47.0300 - 112.5700 1-Yr Rtn: +60.98%

Stock Chart for ALNY

No chart data available.
  • ALNY:US 92.7400
  • 1D
  • 1M
  • 1Y
94.7200
Interactive ALNY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALNY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.1689
Est. EPS (USD) (12/2014) -4.9260
Est. PEG Ratio -
Market Cap (M USD) 7,026.93
Shares Outstanding (M) 76.35
30 Day Average Volume 873,119
Price/Book (mrq) 7.5120
Price/Sale (ttm) 173.4287
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALNY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALNY

Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.

John M MaraganoreChief Executive OfficerBarry E GreenePresident/COO
Akshay K VaishnawExec VP/Chief Medical OfficerLaurence E ReidSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for ALNY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil